|
Wenzel, S, Castro, M, Corren, J, Maspero, J, Wang, L, Zhang, B, Pirozzi, G, Sutherland, ER, Evans, RR, Joish,VN, Eckert, L, Graham, NM, Stahl, N, Yancopoulos, GD, Louis-Tisserand, M, Teper, A. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting ß2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial. Lancet. 2016; Jul2;388(10039): 31-44.
|